As of April 16, 2025, Ascendis Pharma (ASND) has a market cap of $9.25 billion USD. According to our data, Ascendis Pharma is ranked No.1720 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $9.25 B |
12.33%
|
Dec 31, 2024 | $8.24 B |
9.31%
|
Dec 29, 2023 | $7.54 B |
3.13%
|
Dec 30, 2022 | $7.31 B |
-9.22%
|
Dec 31, 2021 | $8.05 B |
-19.34%
|
Dec 31, 2020 | $9.98 B |
19.88%
|
Dec 31, 2019 | $8.33 B |
122.06%
|
Dec 31, 2018 | $3.75 B |
56.39%
|
Dec 29, 2017 | $2.40 B |
97.92%
|
Dec 30, 2016 | $1.21 B |
10.48%
|
Dec 31, 2015 | $1.10 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Novo Nordisk
NVO
|
$286.98 B |
70.023 B
|
![]() Denmark
|
![]() BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
![]() USA
|
![]() Ultragenyx
RARE
|
$3.32 B |
0.000 M
|
![]() USA
|
![]() Radius Recycling (Schnitzer Steel)
RDUS
|
$0.82 B |
5.812 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Ascendis Pharma
ASND
|
$9.25 B |
0.000 M
|
![]() Denmark
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
Market Cap | = | ASND Stock Price | * | ASND Shares Outstanding |
= | $153.92 | * | 60.12 M | |
= | $9.25 B |